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Brucellosis Presenting as Cholecystitis: 
A Case Report and Literature Review
Lisa Speiser, Lanny Hsieh, Susan S. Huang, Cassiana Bittencourt, and Donald Forthal
University of California Irvine
Brucellosis is a zoonotic disease endemic to much of the 
world. It most often presents with nonspecific symptoms and 
is a well known cause of undulant fever. Focal forms occur less 
frequently, with osteoarticular complications being the most 
common. In this study, we describe a rare case of brucellosis 
presenting as cholecystitis.
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Brucellosis, caused by an aerobic, intracellular Gram-negative 
coccobacilli of the genus Brucella, often presents with nonspe-
cific findings of intermittent fever. Focal forms are found in 
30% of patients with osteoarticular manifestations as the most 
common [1, 2]. We present a case of brucellosis cholecystitis 
and review the literature on this rare presentation.
CASE REPORT
A 57-year-old Egyptian male chef and avid eater of unpasteur-
ized cheese presented with right upper quadrant abdominal 
pain in March 2018. White blood cell count (WBC) and liver 
function tests were normal. Ultrasound in the emergency de-
partment (ED) revealed a stone in a contracted gallbladder. 
Cholecystectomy was deferred due to uncertainty if the ultra-
sound findings were the true cause of his pain. Because of con-
tinued pain, he made repeated visits to the ED until November 
2018 when he underwent laparoscopic cholecystectomy. 
Surgery was complicated by severing of an accessary hepatic 
artery and a bile leak. After an unsuccessful endoscopic retro-
grade cholangiopancreatography (ERCP) on postoperative day 
(POD) 2, he was transferred to an academic medical center due 
to concerns for common bile duct injury.
Upon transfer, ERCP demonstrated a truncated common bile 
duct, and an angiogram confirmed ligation of the right hepatic 
artery. White blood cell count was 9600, alkaline phosphatase 
(ALP) 69, alanine aminotransferase (ALT) 160, aspartate 
aminotransferase (AST) 79, and bilirubin (TBILI) 4.5. Blood 
cultures (BCs) obtained on POD 3 were negative. After stabi-
lization and supportive care, he was discharged on POD 5 with 
plans for drain placement by interventional radiology and de-
finitive surgery by hepatobiliary in 6 weeks to achieve sufficient 
collateral formation.
On POD 11, the patient developed fevers, abdominal pain, 
and jaundice. He was found to have a WBC of 27  000, ALP 
255, ALT 432, AST 320, and TBILI 10.7. A  computerized to-
mography scan of the abdomen showed a large biloma above 
the right lobe of the liver extending laterally, medially, and in-
feriorly. The biloma was aspirated percutaneously and drains 
were placed. Cultures from the aspiration and from 1 set of 
BC obtained at admission grew Brucella melitensis. A  serum 
Brucella titer, obtained POD 18, was 1:80. He was initiated on 
doxycycline, and, because streptomycin is not available in the 
United States, he was given a short 1-week course of gentamicin 
[3] to avoid renal toxicity while awaiting surgical correction.
On POD 35, he underwent biliary reconstruction with Roux-
en-Y hepaticojejunostomy. Intraoperatively, he was noted to 
have abscess cavities as well as necrotic and purulent material in 
the gallbladder fossa. Cultures were negative. Postoperatively, he 
continued doxycycline for 6 weeks and was reinitiated on genta-
micin to complete a 2-week course of gentamicin from the time 
of corrective surgery. His abdominal pain and dyspepsia com-
pletely resolved and he remains asymptomatic 4-months later.
Lack of suspicion for brucellosis led to laboratory exposure 
work-up of 25 employees. Six of seven high-risk exposures re-
ceived antimicrobial postexposure prophylaxis (1 declined). 
Per guidelines [4], all exposed workers were monitored sero-
logically and for symptoms. None seroconverted or developed 
brucellosis.
DISCUSSION AND LITERATURE REVIEW
To date, there have been 26 cases of Brucella cholecystitis re-
ported in the literature (Supplementary Table 1). Our patient’s 
clinical syndrome was assumed to be due to consumption of un-
pasteurized cheese, where ingested Brucella invades the mucosa 
and is taken up by local macrophages [5–8]. Here, it remains 
intracellularly and forms membrane-bound compartments [5, 
7–10]. The intravesicular pH acidifies and allows Brucella to 
evade antimicrobials that lack activity in an acidic environment 
[5–8, 10]. The Brucella bacteria replicates and establishes a la-
tent infection that escapes the immune system for years [7, 9, 
11]. We postulate that gallstone-induced cholecystitis allowed 
inflammation to reactivate latent brucellosis, which was amp-
lified by inflammation and pooling of nutritive blood and bile 
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due to the transection of the bile duct and hepatic artery in his 
original surgery. This is consistent with Brucella’s incubation 
period of 1 to 4 weeks [12].
Treatment of brucellosis consists of a combination of anti-
biotics with activity in acidic intracellular environments such 
as the following: tetracyclines, aminoglycosides, and rifampin 
[13]. Secondary therapies include fluoroquinolones and tri-
methoprim/sulfamethoxazole [7]. Monotherapy is associated 
with a relapse rate of 10%–20% [5, 13]. The treatment for com-
plicated, localized disease has not been well established, and the 
optimal duration of treatment is unknown [1]. In the case re-
ports reviewed here, duration of therapy ranged from 8 days to 
6 months, with the most common treatment regimen of strepto-
mycin or gentamicin plus doxycycline for 6 weeks. Three cases 
mention asymptomatic follow-up at 6 weeks [14], 2 months [1], 
and 90 days [15] after 6 weeks, 3.5 months, and 2.5 months of 
treatment, respectively.
CONCLUSION
We report an unusual case of brucellosis presenting as chole-
cystitis after instrumentation and injury in a patient from an 
endemic region. Lack of suspicion of this rare entity necessarily 
resulted in a laboratory exposure work-up.
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